Skip to content
Back to skills

Enda Avoid Long Acting Glucocorticoids Children

ASecurity

Suggests avoiding synthetic, long-acting glucocorticoids (e.g., prednisolone, dexamethasone) in children with primary adrenal insufficiency (PAI). Use when selecting glucocorticoid replacement for a child with PAI to prevent Cushingoid side effects and dose titration difficulties.

  • 12 stars
  • 0 votes
  • 0 copies
  • 5 views
  • Added September 9, 2026
ai-agentsgorails

Works with

  • cli

Security analysis

A100/100

Scanned September 9, 2026

npx -y skills add dromlakhani/MD2SKILL --skill enda-avoid-long-acting-glucocorticoids-children --agent claude-code

Installs into .claude/skills of the current project.

Are you the author of Enda Avoid Long Acting Glucocorticoids Children?

Add the live security badge to your README. It updates with every re-scan.

Security grade badge for Enda Avoid Long Acting Glucocorticoids Children
[![Security: A — Skills Directory](https://www.skillsdirectory.com/api/skills/dromlakhani-enda-avoid-long-acting-glucocorticoids-children/badge)](https://www.skillsdirectory.com/skills/dromlakhani-enda-avoid-long-acting-glucocorticoids-children)

More formats (shields.io, HTML) on the badges page. Keep it an A: scan every change in CI with Pro.

Download with Pro
SKILL.md
---
name: enda-avoid-long-acting-glucocorticoids-children
description: Suggests avoiding synthetic, long-acting glucocorticoids (e.g., prednisolone, dexamethasone) in children with primary adrenal insufficiency (PAI). Use when selecting glucocorticoid replacement for a child with PAI to prevent Cushingoid side effects and dose titration difficulties.
---

# Avoid Synthetic, Long-Acting Glucocorticoids in Children with PAI

## STEP 1 — Gather Information
Confirm diagnosis of PAI in the child (via ACTH stimulation test or clinical/lab criteria) and assess need for glucocorticoid replacement therapy.

## STEP 2 — Rule In / Rule Out
If the child has PAI and requires glucocorticoid replacement, rule out synthetic, long-acting glucocorticoids (prednisolone, dexamethasone) due to risks in pediatric PAI.

## STEP 3 — Classify or Stratify
Classify glucocorticoid options: preferred short-acting agents (hydrocortisone, cortisone acetate) versus avoided long-acting agents (prednisolone, dexamethasone).

## STEP 4 — Decide
Initiate glucocorticoid replacement with hydrocortisone (8 mg/m²/day in three or four divided doses) or cortisone acetate (20–35 mg/day in two or three divided doses); avoid prednisolone and dexamethasone entirely.

## Clinical Guardrails / Mimics / Pitfalls
Do not use dexamethasone due to high risk of Cushingoid side effects and difficulty in dose titration. Avoid prednisolone in children with PAI as it is long-acting and may cause overexposure; if hydrocortisone is unavailable, prednisolone is a last-resort alternative only with extreme caution (per guideline 3.3), but dexamethasone remains least preferred.

## Concrete Clinical Example
A 6-year-old girl with PAI (autoimmune etiology) is started on hydrocortisone 9 mg/m²/day in three divided doses (5 mg/m² morning, 2 mg/m² noon, 2 mg/m² evening) after confirming low cortisol and high ACTH. Prednisolone and dexamethasone are avoided per guideline 3.19.

**Source:** Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI: 10.1210/jc.2015-1710

Attribution

Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.

Comments

Loading comments…

Newsletter

Get the weekly list of safe new skills, and the ones we pulled.